Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market Size By Type (Aneurx Aaa Stent-Graft System, Gore Excluder), By Application (Hospitals, Clinics), By Region, And Segment Forecasts,...

The Global Endovascular Abdominal Aortic Aneurysm (EVAR) Repair Devices Market was valued at USD XX billion in 2023 and is projected to surpass USD XX billion by 2031, growing at a CAGR of XX% during the forecast period of 2023-2031. The increasing prevalence of abdominal aortic aneurysm (AAA), technological advancements in minimally invasive surgical techniques, and the rising preference for endovascular aneurysm repair (EVAR) over open surgery are driving the market growth.

EVAR repair devices, including stent graft systems, provide a less invasive and effective alternative to traditional surgical procedures. These devices reduce hospital stays, lower post-operative complications, and improve patient outcomes. The increasing adoption of advanced imaging techniques and 3D navigation systems is further fueling the demand for EVAR procedures worldwide.

Market Drivers:

1. Rising Incidence of Abdominal Aortic Aneurysm (AAA):

The increasing prevalence of AAA, particularly among the aging population, is a key driver of the market. Factors such as smoking, high blood pressure, and genetic predisposition contribute to the growing number of AAA cases, leading to higher demand for endovascular repair solutions.

2. Technological Advancements in EVAR Devices:

Continuous innovations in EVAR devices, such as customized stent grafts, bioengineered graft materials, and image-guided navigation systems, are enhancing procedural accuracy and efficiency. These advancements are reducing the risk of complications and expanding the eligible patient pool for EVAR.

3. Growing Preference for Minimally Invasive Procedures:

EVAR offers significant benefits over open surgery, including reduced recovery time, lower risk of infection, and shorter hospital stays. As a result, both patients and healthcare providers are increasingly opting for endovascular repair procedures, propelling market growth.

4. Increasing Geriatric Population:

With aging being a major risk factor for AAA, the growing elderly population is driving the demand for advanced aortic aneurysm repair solutions, particularly in developed markets with higher healthcare expenditure.

Market Restraints:

1. High Cost of EVAR Procedures and Devices:

Despite the advantages of EVAR, the high cost of stent graft systems, imaging equipment, and procedural expenses limits adoption, particularly in developing regions with constrained healthcare budgets.

2. Risks Associated with EVAR Procedures:

Complications such as endoleaks, device migration, and aneurysm rupture pose significant challenges in EVAR adoption. Long-term surveillance and the need for secondary interventions add to patient costs and concerns.

3. Limited Access in Low-Income Regions:

The lack of specialized vascular surgeons, inadequate healthcare infrastructure, and reimbursement challenges in emerging markets restricts the widespread adoption of EVAR procedures.

Market Opportunities:

1. Increasing Investments in Healthcare Infrastructure:

Growing investments in vascular centers, diagnostic facilities, and specialized surgical units are enhancing accessibility to EVAR procedures, particularly in developing economies.

2. Development of Next-Generation Stent Grafts:

Manufacturers are focusing on next-gen stent grafts with improved flexibility, durability, and adaptability to complex anatomies, providing new growth opportunities.

3. Rising Adoption of Artificial Intelligence & Robotics:

AI-driven pre-surgical planning tools and robotic-assisted vascular interventions are improving precision, reducing errors, and enhancing patient outcomes, paving the way for market expansion.

Market by Device Type Insights:

1. Percutaneous EVAR Devices:

These devices enable needle-based access to the aorta, reducing the need for open surgical exposure. They are gaining popularity due to lower procedural risks and faster recovery times.

2. Fenestrated EVAR (FEVAR) Devices:

Designed for aneurysms with complex anatomy, these devices allow customized stent grafts with branched configurations for precise deployment.

3. Standard EVAR Devices:

Conventional self-expanding stent grafts dominate the market due to their wide applicability and proven clinical success.

4. Aortic Extensions & Accessories:

Additional components like cuff extensions and iliac branch devices are essential for managing complicated aneurysms and secondary interventions.

Market by End-Use Insights:

1. Hospitals & Surgical Centers:

Hospitals remain the largest end-users, accounting for the majority of EVAR procedures. Increasing investments in vascular surgery units and hybrid operating rooms are driving growth.

2. Ambulatory Surgical Centers (ASCs):

ASCs are witnessing increased adoption of EVAR due to shorter hospital stays, cost-effectiveness, and outpatient treatment feasibility.

3. Specialized Vascular Clinics:

Dedicated vascular clinics are gaining traction, focusing on minimally invasive procedures and follow-up care, enhancing patient accessibility.

Market by Regional Insights:

1. North America:

The United States dominates the EVAR devices market, driven by high adoption of advanced surgical techniques, strong reimbursement policies, and increasing AAA prevalence.

2. Europe:

Countries like Germany, the UK, and France are witnessing increasing EVAR adoption due to technological advancements, growing healthcare spending, and improved screening programs.

3. Asia-Pacific:

China and India are experiencing rapid market expansion due to rising healthcare infrastructure, increasing geriatric population, and government initiatives for vascular care.

4. Latin America & Middle East & Africa (LAMEA):

While growth remains slower, improving healthcare infrastructure and medical tourism initiatives are gradually driving demand for minimally invasive vascular procedures.

Competitive Scenario:

Key players in the Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market include:

Medtronic Plc

Cook Medical Inc.

Terumo Corporation

Endologix LLC

Lombard Medical Limited

Cardinal Health Inc.

Merit Medical Systems, Inc.

Becton, Dickinson, and Company (BD)

CryoLife, Inc.

W.L. Gore & Associates, Inc.

These companies are focusing on technological advancements, regulatory approvals, mergers & acquisitions, and global market expansion to strengthen their presence.

Key Market Developments:

2023: Medtronic launched an AI-assisted EVAR planning tool, improving stent graft selection precision.

2024: Cook Medical introduced a next-gen fenestrated EVAR device, expanding treatment options for complex AAA cases.

2025: Endologix announced a strategic partnership with hospitals in Asia-Pacific, enhancing market penetration.

Scope of Work – Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market